ISIN | LU1159236337 |
---|---|
Valor Number | 29080967 |
Bloomberg Global ID | |
Fund Name | State Street Europe Screened Index Equity Fund I |
Fund Provider |
State Street Global Advisors
Beethovenstrasse 19, 8002 Zürich E-Mail: Switzerland_ICG_team@ssga.com Web: www.ssga.com spdrsswitzerland@ssga.com (ETF Business) |
Fund Provider | State Street Global Advisors |
Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
Distributor(s) | State Street Global Advisors |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The objective of the Fund is to track the performance of the Eurozone equity markets. |
Peculiarities |
Current Price * | 18.14 EUR | 21.11.2024 |
---|---|---|
Previous Price * | 18.06 EUR | 20.11.2024 |
52 Week High * | 19.05 EUR | 27.09.2024 |
52 Week Low * | 16.09 EUR | 28.11.2023 |
NAV * | 18.14 EUR | 21.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 660,053,549 | |
Unit/Share Assets *** | 400,770,172 | |
Trading Information SIX |
YTD Performance | +7.55% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
---|---|---|
YTD Performance (in CHF) | +7.59% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
1 month | -3.72% |
21.10.2024 - 21.11.2024
21.10.2024 21.11.2024 |
3 months | -2.22% |
21.08.2024 - 21.11.2024
21.08.2024 21.11.2024 |
6 months | -3.22% |
21.05.2024 - 21.11.2024
21.05.2024 21.11.2024 |
1 year | +13.00% |
21.11.2023 - 21.11.2024
21.11.2023 21.11.2024 |
2 years | +22.60% |
21.11.2022 - 21.11.2024
21.11.2022 21.11.2024 |
3 years | +12.39% |
22.11.2021 - 21.11.2024
22.11.2021 21.11.2024 |
5 years | +39.63% |
21.11.2019 - 21.11.2024
21.11.2019 21.11.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novo Nordisk AS Class B | 3.45% | |
---|---|---|
ASML Holding NV | 2.61% | |
Nestle SA | 2.39% | |
SAP SE | 2.35% | |
AstraZeneca PLC | 2.13% | |
Roche Holding AG | 2.11% | |
Novartis AG Registered Shares | 2.07% | |
Shell PLC | 2.03% | |
Lvmh Moet Hennessy Louis Vuitton SE | 1.77% | |
HSBC Holdings PLC | 1.63% | |
Last data update | 31.10.2024 |
TER *** | 0.25% |
---|---|
TER date *** | 31.12.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.20% |
Ongoing Charges *** | 0.25% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |